Lymphogranuloma venereum pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lymphogranuloma venereum}} | {{Lymphogranuloma venereum}} | ||
{{CMG}} | {{CMG}} {{AE}} {{NRM}} | ||
==Overview== | |||
==Pathophysiology== | ==Pathophysiology== | ||
| Line 7: | Line 9: | ||
===Transmission=== | ===Transmission=== | ||
LGV | *Lyphogranuloma venereum (LGV) may develop after transmission of [[servars]] L1, L2, or L3 of the bacterium ''[[Chlamydia trachomatis]]''. | ||
*''C. trachomatis'' can be transmitted through vaginal, anal, or oral sexual contact.<ref name="pmid25870512">{{cite journal| author=Ceovic R, Gulin SJ| title=Lymphogranuloma venereum: diagnostic and treatment challenges. | journal=Infect Drug Resist | year= 2015 | volume= 8 | issue= | pages= 39-47 | pmid=25870512 | doi=10.2147/IDR.S57540 | pmc=PMC4381887 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25870512 }} </ref> | |||
*''C. trachomatis'' is an obligate intracellular pathogen.<ref name="pmid25123797">{{cite journal| author=Datta B, Njau F, Thalmann J, Haller H, Wagner AD| title=Differential infection outcome of Chlamydia trachomatis in human blood monocytes and monocyte-derived dendritic cells. | journal=BMC Microbiol | year= 2014 | volume= 14 | issue= | pages= 209 | pmid=25123797 | doi=10.1186/s12866-014-0209-3 | pmc=PMC4236547 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25123797 }} </ref> | |||
===Pathogenesis=== | |||
==References== | ==References== | ||
Revision as of 15:01, 9 February 2016
|
Lymphogranuloma venereum Microchapters |
|
Differentiating Lymphogranuloma venereum from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphogranuloma venereum pathophysiology On the Web |
|
American Roentgen Ray Society Images of Lymphogranuloma venereum pathophysiology |
|
Risk calculators and risk factors for Lymphogranuloma venereum pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nate Michalak, B.A.
Overview
Pathophysiology
Lymphogranuloma venereum (LGV) is a chronic (long-term) infection of the lymphatic system caused by three different types of the bacteria Chlamydia trachomatis. The bacteria spread through sexual contact. The infection is caused by a different bacteria than that which causes genital chlamydia.
Transmission
- Lyphogranuloma venereum (LGV) may develop after transmission of servars L1, L2, or L3 of the bacterium Chlamydia trachomatis.
- C. trachomatis can be transmitted through vaginal, anal, or oral sexual contact.[1]
- C. trachomatis is an obligate intracellular pathogen.[2]
Pathogenesis
References
- ↑ Ceovic R, Gulin SJ (2015). "Lymphogranuloma venereum: diagnostic and treatment challenges". Infect Drug Resist. 8: 39–47. doi:10.2147/IDR.S57540. PMC 4381887. PMID 25870512.
- ↑ Datta B, Njau F, Thalmann J, Haller H, Wagner AD (2014). "Differential infection outcome of Chlamydia trachomatis in human blood monocytes and monocyte-derived dendritic cells". BMC Microbiol. 14: 209. doi:10.1186/s12866-014-0209-3. PMC 4236547. PMID 25123797.